Healthcare Triangle, Inc.: Healthcare Triangle Reports 322% Increase in Gross Profit and 158% Increase in Revenue for Q2 2026
Healthcare Triangle, Inc. (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19M, up 158% year over year, and gross profit of $2.07M, up 322%. The AI platform contributed about 69% of revenue and gross margin rose to 22.5% from 13.8%. The Teyame and Datono acquisition contributed $6.31M revenue. Stockholders’ equity rose to $49.1M from $9.9M.
How this was made
The 30-second read
Why it matters
Q2 2026 performance highlights sustained acquisition momentum, with the acquired businesses contributing $6.31M revenue and driving gross margin expansion to 22.5%. Equity increased materially, suggesting improved liquidity/financial flexibility.
Market read
Traders can reassess near-term growth expectations and margin trajectory based on the reported quarter and the equity/liquidity improvement, though the release lacks forward guidance.
What to watch
Gross margin improved to 22.5% from 13.8%, but the release does not break out operating expenses, cash flow, or customer concentration, which are key to assessing sustainability.
Background
Healthcare Triangle is an AI-powered customer engagement and digital transformation services provider, and it completed the Teyame and Datono acquisition in January 2026.
Ticker impact
Healthcare Triangle reported Q2 2026 revenue of $9.19M (+158% YoY) and gross profit of $2.07M (+322% YoY).
Likely near-term positive bias as traders price in sustained acquisition-driven growth and improved gross margin.
This is a primary earnings-style release with multiple hard datapoints: revenue, gross profit, gross margin expansion, segment contribution, and stockholders' equity rising to $49.1M from $9.9M. However, no forward guidance or valuation context is provided, limiting conviction on magnitude/duration of the move.
Market effects
Reinforces demand for AI-powered customer engagement and digital transformation services in healthcare IT, potentially supportive for similar small-cap HIT vendors.
No specific regional market linkage beyond US healthcare IT.
Limited, as the disclosure is company-specific and acquisition-related without broader cross-border policy or macro drivers.
Counterpoint
The results may be heavily acquisition-concentrated (69% of revenue from the acquired businesses), so organic durability and customer retention risk could be underappreciated.
Key entities
- public_companyHealthcare Triangle, Inc.
Nasdaq-listed healthcare IT services company reporting Q2 2026 results and acquisition-driven growth.
- acquired_businessTeyame 360 S.L.
Acquired business contributing $6.31M revenue in Q2 2026 via the integrated AI-powered omnichannel platform.
- acquired_businessDatono Mediacion S.L.
Acquired business contributing to the integrated platform and driving revenue and gross profit growth in Q2 2026.
- executiveDavid Ayanoglou
CFO quoted on sustained segment contribution and balance-sheet strengthening.
